• All
  • News
All
  • All
  • News

New publication in Blood Reviews

Update: The molecular spectrum of virus-associated high-grade B-cell non-Hodgkin lymphomas

New publication in Annals of Hematology

Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations

Certification as Center for Personalized Medicine – Oncology

The Molecular Tumor Board of the University Cancer Center Schleswig-Holstein has been certified as a center for personalized medicine by the DKG (Deutsche Krebsgesellschaft; German

Passed NGS quality assessment

We passed this years quality assessment for NGS sequencing. Since 2022 we participate in the external quality assessment programme for Next-Generation Sequencing by the BVDH

New publication in JMIR Medical Informatics

Extending cBioPortal for Therapy Recommendation Documentation in Molecular Tumor Boards: Development and Usability Study

CRC 1665 granted

Our CRC 1665 appplication „Determinants, meanings and implications of sex diversity in sociocultural, medical and biological landscapes“ is funded. We are involved in two work